CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- Open-market buys, last 90 days
- $1,379,662
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,379,662. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-11 | Booth Andrew Chief Financial Officer | Purchase | +53,500 | $14.74 | $789K | 53,500 |
| 2021-11-11 | Booth Andrew Chief Financial Officer | Purchase | +14,000 | $14.61 | $205K | 130,959 |
| 2021-11-11 | Thermopylae Holdings Ltd. 10% owner | Purchase | +202,960 | $14.76 | $3.0M | 55,807,290 |
| 2021-09-13 | Hayden Michael R Director | Option exercise | +270,000 | $17.73 | $4.8M | 1,273,397 |
| 2021-09-13 | Hayden Michael R Director | Option exercise · Share option (right to buy) | +270,000 | 270,000 | ||
| 2021-09-01 | Falconer Ester Chief Technology Officer | Option exercise | +875,000 | $16.89 | $14.8M | 875,000 |
| 2021-09-01 | Falconer Ester Chief Technology Officer | Option exercise · Share option (right to buy) | −875,000 | 875,000 | ||
| 2021-09-01 | HAMER JOHN Director | Sale | −137,351 | $16.93 | $2.3M | 128,862 |
| 2021-08-31 | HAMER JOHN Director | Sale | −162,649 | $16.95 | $2.8M | 266,213 |
| 2021-08-27 | Montalbano John S. Director | Grant or award · Share option (right to buy) | +34,282 | 534,282 | ||
| 2021-08-27 | Hayden Michael R Director | Grant or award · Share option (right to buy) | +34,282 | 674,282 | ||
| 2021-08-16 | Montalbano John S. Director | Purchase | +6,000 | $17.23 | $103K | 26,000 |
| 2021-06-22 | Hayden Michael R Director | Sale | −100,000 | $25.50 | $2.5M | 1,003,397 |
| 2021-06-18 | DCVC Bio, L.P. 10% owner | Other disposition | −5,000,000 | 24,105,761 | ||
| 2021-06-18 | DCVC Bio, L.P. 10% owner | Other acquisition | +73,892 | 73,892 | ||
| 2021-06-18 | HAMER JOHN Director | Other disposition | −5,000,000 | 24,105,761 | ||
| 2021-06-18 | HAMER JOHN Director | Other acquisition | +73,892 | 73,892 | ||
| 2021-06-15 | Lecault Veronique Chief Operating Officer | Option exercise | +333,333 | $0.19 | $63K | 1,339,333 |
| 2021-06-15 | Lecault Veronique Chief Operating Officer | Option exercise · Share Option (right to buy) | −333,333 | 666,667 | ||
| 2021-06-09 | Thermopylae Holdings Ltd. 10% owner | Sale | −5,598,420 | $24.03 | $134.5M | 55,604,330 |
Page 7 of 11 · 203 trades